Orthocell’s (ASX:OCC) revenue of $3.2 million for the December quarter of 2025 is also a strong indicator of the early success of its expansion into North American markets. OCC’s latest quarterly ...

Economist Ludwig von Mises famously described economics as the study of human activity in a world of limited resources and unlimited wants. Central to his thinking was the idea that individuals must ...

Realty Income offers the highest yield at 5.62% and pays dividends monthly instead of quarterly. AbbVie raised its dividend 5.5% to $6.92 annually with revenue up 9.1% to $15.8B. Procter & Gamble ...

Is allowing publicly traded companies to file earnings reports semiannually rather than quarterly a good idea? In September, President Donald Trump called for the Securities and Exchange Commission to ...

On the heels of a big beat with its latest quarterly results, Nvidia CEO Jensen Huang said sales of the company's Blackwell offering are "off the charts." Meanwhile, graphics processing units for the ...

Matthew Ricketson does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Strategy announced plans to sell 3.5 million shares of its new 10.00% Series A Perpetual Stream Preferred Stock (STRE). The issue will be registered under the U.S. Securities Act of 1933 and offered ...

Less than a week after Strategy (MSTR) reported Q3 earnings and hinted at launching an international perpetual preferred stock, the company has brought Stream (STRE) to market, a euro-denominated ...

Monthly dividends offer faster compounding, outperforming the Schwab U.S. Dividend Equity ETF (SCHD) quarterly payouts with stronger long-term returns. Both ETFs below beat SCHD’s 12.2% 10-year ...

Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. In April 2025, the U.S. Food and Drug Administration ...

A Kennett Square pharmacy must pay a $1 million civil penalty to resolve a state investigation that found it was producing and packaging thousands of doses of injectable weight loss drugs without ...